Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "DoP"

699 News Found

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery
Hospitals | May 20, 2026

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery

A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern


India’s opportunity to build preventive healthcare economy
Opinion | May 19, 2026

India’s opportunity to build preventive healthcare economy

The country’s strength lies not just in technology availability but in adoption behaviour


Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare
interviews | May 18, 2026

Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare

Access to genomic testing, not therapy cost, is the biggest challenge


Mankind launches ‘Act at 30’ campaign to push early heart health screening
Healthcare | May 18, 2026

Mankind launches ‘Act at 30’ campaign to push early heart health screening

Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone


Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Biopharma | May 18, 2026

Kotak Alts invests Rs. 200 million in Cellogen Therapeutics

Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities


Suven Life Sciences reaches 76% milestone in Phase 3 masupirdine trial for Alzheimer’s agitation
Clinical Trials | May 14, 2026

Suven Life Sciences reaches 76% milestone in Phase 3 masupirdine trial for Alzheimer’s agitation

The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies


AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
interviews | May 13, 2026

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution


Plus Therapeutics subsidiary clears key Medicare milestone
News | May 12, 2026

Plus Therapeutics subsidiary clears key Medicare milestone

Paves way for CNS cancer test rollout


NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs
R&D | May 12, 2026

NIH-funded study uncovers hidden brain circuit behind GLP-1 weight-loss drugs

In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike


6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders
Clinical Trials | May 11, 2026

6th Drug Safety Symposium 2026 to convene over 100 pharmacovigilance leaders

Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption